Anti-parasite drugs 'affect lamb development'
AgResearch scientists have collected the first known data showing behavioural developmental impacts on lambs whose mothers were treated with long-acting drugs for parasites.
As a trusted partner in New Zealand’s dairy industry since mid-1970, FIL places innovation and customer-centricity at the core of its approach. With more dairy companies offering incentives for high-quality milk, FIL is stepping up to take a leadership role in udder health and mastitis management. Their mission is to deliver products and services that tackle industry challenges, creating real value for farmers.
“We want to understand where Kiwi farmers are on their journey towards lower somatic cell counts and healthier animals,” says Jamie Barrett, FIL Product Lead for Asia Pacific.
“There is a carrot being dangled in front of farmers to better manage mastitis. Until we fully understand the problems and the barriers for addressing them, we are running blind with helping farmers get there.
“This survey will help us understand where we need to put our focus to accelerate outcomes for dairy farmers.”
Survey participants will also have the chance to win a year’s supply of FIL udder health products, valued at up to $15,000 (recommended retail price).
The survey, conducted by Farmers Industries (NZ) Limited, a subsidiary of GEA Farm Technologies, will remain open until Thursday, 21 November.
To participate, visit www.fil.co.nz/udder-health-survey
